Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytes
Andrew Simonson(University of Pittsburgh), JoAnne L. Flynn(University of Pittsburgh), Charles A. Scanga(University of Pittsburgh), Allison N. Bucşan(National Institutes of Health), Chelsea C. Lehman(National Institutes of Health), Supriya Pokkali(National Institutes of Health), Ryan J. Kelly(University of Pittsburgh), Michael C. Chao(Brigham and Women's Hospital), H. Jacob Borish(University of Pittsburgh), Philana Ling Lin(Children's Hospital of Pittsburgh), Amy J. Myers(University of Pittsburgh), Edwin Klein(University of Pittsburgh), Jaime Tomko(University of Pittsburgh), Cassaundra L. Ameel(University of Pittsburgh), Matthew S. Sutton(National Institutes of Health), Pauline Maiello(University of Pittsburgh), Mark A. Rodgers(University of Pittsburgh), Robert A. Seder(National Institutes of Health), Harris B. Chishti(University of Pittsburgh), Joseph J. Zeppa(University of Pittsburgh), Caylin G. Winchell(University of Pittsburgh), Sarah M. Fortune(Harvard University), Michael R. Chase(Harvard University), Mario Roederer(Office of the Director), Ben Krouse(University of Pittsburgh), Rachel Donlan(University of Pittsburgh), Andrew J Vickers(Harvard University), M. Panduranga Kamath(National Institutes of Health), Forrest Hopkins(Harvard University), Luke E Hood(University of Pittsburgh), Patricia A. Darrah(National Institutes of Health)
Cited by 34
Related Papers
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k
Definitions and guidelines for research on antibiotic persistence
|Nature Reviews Microbiology|2019|1.3k
Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing
|Nature Biotechnology|2012|380
Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry
|Nature Medicine|2006|368